{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:40:32Z","timestamp":1771548032432,"version":"3.50.1"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:sec id=\"ab-ioi220068-4\"><jats:title>Importance<\/jats:title><jats:p>Since 1996, the US Preventive Services Task Force has recommended against cervical cancer screening in average-risk women 65 years or older with adequate prior screening. Little is known about the use of cervical cancer screening\u2013associated services in this age group.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi220068-5\"><jats:title>Objective<\/jats:title><jats:p>To examine annual use trends in cervical cancer screening\u2013associated services, specifically cytology and human papillomavirus (HPV) tests, colposcopy, and cervical procedures (loop electrosurgical excision procedure, cone biopsy, and ablation) in Medicare fee-for-service beneficiaries during January 1, 1999, to December 31, 2019, and estimate expenditures for services performed in 2019.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi220068-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This population-based, cross-sectional analysis included health service use data across 21 years for women aged 65 to 114 years with Medicare fee-for-service coverage (15-16 million women per year). Data analysis was conducted between July 2021 and April 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi220068-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Proportion of testing modalities (cytology alone, cytology plus HPV testing [cotesting], HPV testing alone); annual use rate per 100\u202f000 women of cytology and HPV testing, colposcopy, and cervical procedures from 1999 to 2019; Medicare expenditure for these services in 2019.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi220068-8\"><jats:title>Results<\/jats:title><jats:p>There were 15\u202f323\u202f635 women 65 years and older with Medicare fee-for-service coverage in 1999 and 15\u202f298\u202f656 in 2019. In 2019, the mean (SD) age of study population was 76.2 (8.1) years, 5.1% were Hispanic, 0.5% were non-Hispanic American Indian\/Alaska Native, 3.0% were non-Hispanic Asian\/Pacific Islander, 7.4% were non-Hispanic Black, and 82.0% were non-Hispanic White. From 1999 to 2019, the percentage of women who received at least 1 cytology or HPV test decreased from 18.9% (2.9 million women) in 1999 to 8.5% (1.3 million women) in 2019, a reduction of 55.3%; use rates of colposcopy and cervical procedures decreased 43.2% and 64.4%, respectively. Trend analyses showed a 4.6% average annual reduction in use of cytology or HPV testing during 1999 to 2019 (<jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Use rates of colposcopy and cervical procedures decreased before 2015 then plateaued during 2015 to 2019. The total Medicare expenditure for all services rendered in 2019 was about $83.5 million. About 3% of women older than 80 years received at least 1 service at a cost of $7.4 million in 2019.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi220068-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The results of this cross-sectional study suggest that while annual use of cervical cancer screening\u2013associated services in the Medicare fee-for-service population older than 65 years has decreased during the last 2 decades, more than 1.3 million women received these services in 2019 at substantial costs.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamainternmed.2022.5261","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T16:33:51Z","timestamp":1669048431000},"page":"11","source":"Crossref","is-referenced-by-count":12,"title":["Use Trends and Recent Expenditures for Cervical Cancer Screening\u2013Associated Services in Medicare Fee-for-Service Beneficiaries Older Than 65 Years"],"prefix":"10.1001","volume":"183","author":[{"given":"Jin","family":"Qin","sequence":"first","affiliation":[{"name":"Division of Cancer Prevention and Control, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter K.","family":"Holt","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of Illinois at Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Richards","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Control, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Saraiya","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Control, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George F.","family":"Sawaya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco"},{"name":"UCSF Center for Healthcare Value, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"12","key":"ioi220068r2","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1002\/cam4.v10.12","article-title":"A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.","volume":"10","author":"Benard","year":"2021","journal-title":"Cancer Med"},{"issue":"6","key":"ioi220068r4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer.","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"ioi220068r5","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"ACOG Practice Bulletin no. 109: Cervical cytology screening.","volume":"114","author":"American College of Obstetricians and Gynecologists","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"ioi220068r6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"16","author":"Saslow","year":"2012","journal-title":"J Low Genit Tract Dis"},{"issue":"7","key":"ioi220068r7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"ioi220068r9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"5","key":"ioi220068r10","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG practice bulletin number 131: screening for cervical cancer.","volume":"120","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"ioi220068r11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.v70.5","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"ioi220068r12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ypmed.2017.10.019","article-title":"Comparing cancer screening estimates: behavioral risk factor surveillance system and national health interview survey.","volume":"106","author":"Sauer","year":"2018","journal-title":"Prev Med"},{"key":"ioi220068r13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ypmed.2017.05.004","article-title":"National assessment of HPV and pap tests: changes in cervical cancer screening, National Health Interview Survey.","volume":"100","author":"Watson","year":"2017","journal-title":"Prev Med"},{"issue":"2","key":"ioi220068r14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamainternmed.2013.12607","article-title":"Overuse of Papanicolaou testing among older women and among women without a cervix.","volume":"174","author":"Kepka","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"1","key":"ioi220068r15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.43582","article-title":"Assessment of US Preventive Services Task Force guideline\u2013concordant cervical cancer screening rates and reasons for underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019.","volume":"5","author":"Suk","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"ioi220068r16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15585\/mmwr.mm7002a1","article-title":"Cancer screening test receipt\u2014United States, 2018.","volume":"70","author":"Sabatino","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"ioi220068r19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10552-017-0976-x","article-title":"Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and pap\/HPV cotesting in women aged 30-65 years.","volume":"29","author":"Silver","year":"2018","journal-title":"Cancer Causes Control"},{"key":"ioi220068r20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.pmedr.2018.01.010","article-title":"Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014.","volume":"9","author":"Watson","year":"2018","journal-title":"Prev Med Rep"},{"issue":"8","key":"ioi220068r21","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/cid\/ciy707","article-title":"Trends in high-grade cervical lesions and cervical cancer screening in 5 states, 2008-2015.","volume":"68","author":"Gargano","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ioi220068r22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/jwh.2018.7380","article-title":"Trends over time in pap and pap-HPV cotesting for cervical cancer screening.","volume":"28","author":"MacLaughlin","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"2 Pt 1","key":"ioi220068r23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/AOG.0b013e3182253c33","article-title":"Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory.","volume":"118","author":"Phelan","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"2","key":"ioi220068r24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ygyno.2021.08.023","article-title":"Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.","volume":"163","author":"Qin","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"6","key":"ioi220068r25","first-page":"e137","article-title":"Ambulatory care visits for pap tests, abnormal pap test results, and cervical cancer procedures in the United States.","volume":"16","author":"Saraiya","year":"2010","journal-title":"Am J Manag Care"},{"issue":"12","key":"ioi220068r26","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1007\/s11606-021-06784-8","article-title":"The utilization and costs of grade D USPSTF services in Medicare, 2007-2016.","volume":"36","author":"Oronce","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"2","key":"ioi220068r27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/LGT.0000000000000454","article-title":"Observed colposcopy practice in US community-based clinics: the retrospective control arm of the IMPROVE-COLPO study.","volume":"23","author":"Huh","year":"2019","journal-title":"J Low Genit Tract Dis"},{"issue":"11","key":"ioi220068r31","first-page":"101","article-title":"Screening for cervical cancer: recommendations and rationale.","volume":"103","author":"U.S. Preventive Services Task Force","year":"2003","journal-title":"Am J Nurs"},{"issue":"2","key":"ioi220068r32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ygyno.2021.05.035","article-title":"Eligibility for cervical cancer screening exit: comparison of a national and safety net cohort.","volume":"162","author":"Mills","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"6","key":"ioi220068r33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.amepre.2019.08.011","article-title":"Adherence to cervical cancer screening guidelines among women aged 66-68 years in a large community-based practice.","volume":"57","author":"Chao","year":"2019","journal-title":"Am J Prev Med"},{"issue":"10","key":"ioi220068r34","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1089\/jwh.2019.8017","article-title":"Prevalence of inadequate cervical cancer screening in low-income older women.","volume":"29","author":"Cejtin","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"issue":"13","key":"ioi220068r35","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1002\/cncr.v127.13","article-title":"Cancer diagnoses and survival rise as 65-year-olds become Medicare-eligible.","volume":"127","author":"Patel","year":"2021","journal-title":"Cancer"},{"issue":"11","key":"ioi220068r36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11912-020-00968-x","article-title":"Cancer screening among older adults: a geriatrician\u2019s perspective on breast, cervical, colon, prostate, and lung cancer screening.","volume":"22","author":"Kotwal","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"ioi220068r38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijgo.2015.07.026","article-title":"Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia.","volume":"132","author":"Santesso","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"ioi220068r39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170587","article-title":"Comparison of cold-knife conization versus loop electrosurgical excision for cervical adenocarcinoma in situ (ACIS): a systematic review and meta-analysis.","volume":"12","author":"Jiang","year":"2017","journal-title":"PLoS One"},{"key":"ioi220068r40","doi-asserted-by":"publisher","DOI":"10.1177\/2333392818755241","article-title":"Ending cervical cancer screening in low-risk women after age 65: understanding barriers to adherence with evidence-based guidelines among primary care providers.","volume":"5","author":"Boone","year":"2018","journal-title":"Health Serv Res Manag Epidemiol"},{"issue":"10","key":"ioi220068r41","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1001\/jamainternmed.2014.3895","article-title":"Cancer screening rates in individuals with different life expectancies.","volume":"174","author":"Royce","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"11","key":"ioi220068r42","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1158\/1055-9965.EPI-20-0673","article-title":"Risk of injuries around diagnosis of cervical cancer and its precursor lesions: a nationwide cohort study in Sweden.","volume":"29","author":"Shen","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"ioi220068r43","doi-asserted-by":"publisher","DOI":"10.1177\/2381468320952409","article-title":"Discussing cervical cancer screening options: outcomes to guide conversations between patients and providers.","volume":"5","author":"Holt","year":"2020","journal-title":"MDM Policy Pract"},{"issue":"3","key":"ioi220068r44","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/pam.v39.3","article-title":"Does Medicare coverage improve cancer detection and mortality outcomes?","volume":"39","author":"Myerson","year":"2020","journal-title":"J Policy Anal Manage"},{"issue":"8","key":"ioi220068r45","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/jgs.v69.8","article-title":"Effect of new Medicare enrollment on health, healthcare utilization, and cost: a scoping review.","volume":"69","author":"Yeung","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"ioi220068r46","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ypmed.2019.04.010","article-title":"Trends in cervical cancer incidence rates by age, race\/ethnicity, histological subtype, and stage at diagnosis in the United States.","volume":"123","author":"Islami","year":"2019","journal-title":"Prev Med"},{"issue":"2","key":"ioi220068r47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172548","article-title":"Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.","volume":"12","author":"Yoo","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"ioi220068r48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors.","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"ioi220068r49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10552-021-01496-0","article-title":"US hysterectomy prevalence by age, race and ethnicity from BRFSS and NHIS: implications for analyses of cervical and uterine cancer rates.","volume":"33","author":"Adam","year":"2022","journal-title":"Cancer Causes Control"},{"issue":"2","key":"ioi220068r50","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/jrh.v38.2","article-title":"Higher prevalence of hysterectomy among rural women than urban women: implications for measures of disparities in uterine and cervical cancers.","volume":"38","author":"Adam","year":"2022","journal-title":"J Rural Health"},{"issue":"8","key":"ioi220068r52","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1007\/s11606-020-05826-x","article-title":"Primary care utilization and expenditures in traditional Medicare and Medicare Advantage, 2007-2016.","volume":"35","author":"Park","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"3","key":"ioi220068r53","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.1762","article-title":"Trends in use of low-value care in traditional fee-for-service Medicare and Medicare Advantage.","volume":"4","author":"Park","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"ioi220068r54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/20476965.2019.1581433","article-title":"Key considerations when using health insurance claims data in advanced data analyses: an experience report.","volume":"9","author":"Konrad","year":"2019","journal-title":"Health Syst (Basingstoke)"},{"key":"ioi220068r3","volume-title":"US Preventive Services Task Force Guides to Clinical Preventive Services","author":"Agency for Healthcare Research and Quality","year":"1996","edition":"2nd edition"},{"key":"ioi220068r29","volume-title":"Age and sex composition: 2010","author":"Howden","year":"2011"},{"key":"ioi220068r1","unstructured":"US Centers for Disease Control and Prevention and National Cancer Institute. United States cancer statistics\u2014incidence and mortality, 1999-2018. Accessed April 19, 2022. https:\/\/wonder.cdc.gov\/cancer-v2018.html"},{"key":"ioi220068r8","unstructured":"American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Accessed March 28, 2022. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/04\/updated-cervical-cancer-screening-guidelines"},{"key":"ioi220068r17","unstructured":"National Center for Health Statistics. National Health Interview Survey, 2019: public-use data file and documentation. Accessed February 19, 2021. ftp:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/Dataset_Documentation\/NHIS\/2019\/adult-codebook.pdf"},{"key":"ioi220068r18","unstructured":"US Centers for Disease Control and Prevention. Behavioral risk factor surveillance system survey data. Accessed February 19, 2021, https:\/\/www.cdc.gov\/brfss\/annual_data\/2018\/pdf\/codebook18_llcp-v2-508.pdf"},{"key":"ioi220068r28","unstructured":"US Centers for Medicare & Medicaid Services. CCW Medicare administrative data user guide, version 3.6. Accessed March 16, 2022. https:\/\/www2.ccwdata.org\/web\/guest\/user-documentation"},{"key":"ioi220068r30","unstructured":"National Cancer Institute. Joinpoint regression program: version 4.9.0.0. Accessed April 22, 2022. https:\/\/surveillance.cancer.gov\/joinpoint\/"},{"key":"ioi220068r37","unstructured":"Social Security Administration. 2019 Actuarial life table. Accessed April 4, 2022. https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html"},{"key":"ioi220068r51","unstructured":"National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Accessed August 22, 2022. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/human-0#:~:text=Women%20with%20HIV%20Aged%20%3C30,every%203%20years%20(BII)"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2798311\/jamainternal_qin_2022_oi_220068_1672531901.98248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T16:18:41Z","timestamp":1672762721000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2798311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2022.5261","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}